Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Combination Glacaprivir/pibrentasvir-vv 86 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Ribociclib-vv 86, Medicines 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Rifaximin-vv 86 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Natalizumab (ilo) -vv 86 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Capsaicin (quenza) -vv 86 2026-02-15
Germany Open House Original Discount Contracts 202522 Aclidinium Bromide 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Combination Emtrictabin/rilpivirin/tenofovir-vv 86 2026-02-15
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Ingredient Dupilumab-vv 86 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Felbamat-vv 86 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Sirolimus-vv 86 2026-02-15
Whats app